Part D Redesign: MedPAC Finalizes Recommendations To Congress But COVID-19 Will Get In The Way

Plan includes new 30% manufacturer discount in the US Medicare Part D catastrophic phase, which manufacturers will oppose as too high. But it also caps beneficiary cost sharing, a long-sought industry goal.

Pills
MedPAC Aims To Tamp Down Specialty Drug Costs In Part D

More from Market Access

More from Pink Sheet